Edgar Snyder & Associates®
A Law Firm Representing Injured People
Call Us Toll Free 24/7
Published on Mar 24, 2006 by Edgar Snyder

ADHD Drugs Not to Get "Black Box" Warning

ADHD Drugs

A federal advisory panel came to the conclusion that drugs used to treat attention deficit hyperactivity disorder (ADHD) do not need to carry a “black-box” warning, the government’s strongest, alerting users of psychiatric and cardiovascular risks.

However, the Food and Drug Administration (FDA) pediatric advisory committee determined the drug labels should highlight the possible dangers in plain language easily understood by patients. The updated labels may not appear until companies begin using a newly adopted format that may take several years to put into effect.

Still, the FDA could decide to require “black-box” warnings on drugs used to treat ADHD that would alert adults of the increased risk of heart attack, stroke, and other serious problems.

Psychiatrists and other experts asked the committee to be cautious before recommending strengthened warnings associated with ADHD drugs. They felt adding the “black-box” warning would cause more harm than good.

For more information about dangerous drugs, visit the Recalled Drugs and Other Drug Alerts Legal Center.

Drug litigation may involve co-counsel.

Source: “ADHD Drugs Clear Warnings, Group Advises.” The Associated Press. March 24, 2006.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
Briefly describe your injuries

Recent News

Sep 28, 2016
Pittsburgh Police Beefing Up DUI Patrols in 2017
Sep 26, 2016
Gear Up, Cool Down, and Stay Safe While Riding This Fall
Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers
Sep 16, 2016
Smartphone Apps for Drivers